Jeffrey Perl

MD, FRCP(C), SM

Investigator

Biography

Dr Jeffrey Perl is a staff nephrologist at, St Michael’s Hospital in Toronto and Associate Professor of Medicine at the University of Toronto. He received his Master of Science in Epidemiology from The Harvard School for Public Health. He is a prior recipient of The John Maher Young Investigator Award by the International Society for Peritoneal Dialysis and has received several teaching awards at The University of Toronto and St. Michael’s Hospital. He serves as the current editor-in-chief of Peritoneal Dialysis International.  He is also chair of the home dialysis subcommittee of the American Society of Nephrology COVID-19 response team. His primary research interests and clinical practice focuses on improving the survival and quality of life for patients on home dialysis. Dr. Perl is a primary investigator in The International Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) and principal investigator of the Optimizing the Prevention of Peritoneal Dialysis Associated Peritonitis in The United States (OPPUS) study.

Recent Publications

  1. Shapiro, J, Schiff, J, Perl, J. Peritoneal dialysis and kidney transplantation: Your questions answered. Perit Dial Int. 2025; :8968608251313679. doi: 10.1177/08968608251313679. PubMed PMID:39871717 .
  2. McGrath, A, Perl, J, Brown, EA. Peritoneal Dialysis Modality Choice: Not an Automated Decision. Clin J Am Soc Nephrol. 2024; :. doi: 10.2215/CJN.0000000627. PubMed PMID:39665583 .
  3. Tennankore, KK, McCullough, K, Bieber, B, Cho, Y, Johnson, DW, Kanjanabuch, T et al.. Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus: International Results from Peritoneal Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2024;19 (12):1622-1634. doi: 10.2215/CJN.0000000000000537. PubMed PMID:39652652 PubMed Central PMC11637705.
  4. Sakurada, T, Zhao, J, Tu, C, Bieber, B, Cheetham, M, Pisoni, RL et al.. Effects of initial peritoneal dialysis prescription on clinical outcomes in Japanese peritoneal dialysis patients: a cohort study. Sci Rep. 2024;14 (1):30109. doi: 10.1038/s41598-024-81934-6. PubMed PMID:39627492 PubMed Central PMC11614897.
  5. Shen, JI, Perl, J. Disparities in Care: Desperate for Modality Education. J Am Soc Nephrol. 2025;36 (1):16-18. doi: 10.1681/ASN.0000000578. PubMed PMID:39625792 PubMed Central PMC11706551.
  6. Al Sahlawi, M, Chan, CT, Perl, J. Infection prevention in home dialysis. Curr Opin Nephrol Hypertens. 2025;34 (1):95-103. doi: 10.1097/MNH.0000000000001032. PubMed PMID:39499062 .
  7. Tennankore, KK, McCullough, KP, Bieber, B, Cho, Y, Johnson, DW, Kanjanabuch, T et al.. Prevalence and Outcomes of Chronic Kidney Disease Associated Pruritus: International Results from PDOPPS. Clin J Am Soc Nephrol. 2024; :. doi: 10.2215/CJN.0000000000000537. PubMed PMID:39392697 .
  8. Lim, JH, Seo, YJ, Pecoits-Filho, R, Bieber, B, Perl, J, Johnson, DW et al.. The impact of shortening patient-doctor contact duration on early peritoneal dialysis-related infections. Sci Rep. 2024;14 (1):22955. doi: 10.1038/s41598-024-74205-x. PubMed PMID:39362978 PubMed Central PMC11449936.
  9. Mustafa, W, Perl, J, Al Sahlawi, M. Early innovation to avoid late peritonitis-related complications. Perit Dial Int. 2024;44 (6):401-403. doi: 10.1177/08968608241286470. PubMed PMID:39344407 .
  10. Ito, Y, Tu, C, Yamaguchi, M, Koide, S, Ryuzaki, M, Bieber, B et al.. Risk factors of peritoneal dialysis-related peritonitis in the Japan Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Clin Kidney J. 2024;17 (7):sfae202. doi: 10.1093/ckj/sfae202. PubMed PMID:39050865 PubMed Central PMC11267232.
Search PubMed

Affiliations & Other Activities

  • Nephrologist, Division of Nephrology, St. Michael’s Hospital
  • Assistant Professor of Medicine, University of Toronto
  • Chair, International Society of Nephrology’s Young Nephrologists Committee